Supraclinical concentrations of dexmedetomidine evoke norepinephrine release from rat cerebrocortical slices: Possible involvement of the orexin-1 receptor

Neuroscience Letters

Volumn 372, Issue 1-2, 2004, Pages 142-145

  Hirota, Kazuyoshi ^a   Nomura, Hiroki ^a   Kudo, Mihoko ^a   Mori, Naohiro ^a   Kudo, Tsuyoshi ^a   Kushikata, Tetsuya ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

2 Adrenoceptor; Cerebrocortex; Clonidine; Dexmedetomidine; Norepinephrine; OX 1 antagonist; Rats

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; DEXMEDETOMIDINE; NEUROPEPTIDE RECEPTOR; NORADRENALIN; OREXIN 1 RECEPTOR; OREXIN 1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CONCENTRATION RESPONSE; EVOKED RESPONSE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CEREBRAL CORTEX; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 8644234262     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.09.027     Document Type: Article

References (29)

1. A. Angel, A.B. Majeed, Alterations of "sleeping time" in the rat induced by drugs which modulate central monoaminergic systems, Br. J. Anaesth. 64, 594-600.
2. P. Bourgin, S. Huitron-Resendiz, A.D. Spier, V. Fabre, B. Morte, J.R. Criado, J.G. Sutcliffe, S.J. Henriksen, and L. de Lecea Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons J. Neurosci. 20 2000 7760 7765
3. 2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus: voltammetric data Eur. J. Pharmacol. 366 1999 35 39
4. T.J. Ebert, J.E. Hall, J.A. Barney, and T.D. Uhrich The effects of increasing plasma concentrations of dexmedetomidine in humans Anesthesiology 93 2000 382 394
5. R.A. Espana, S. Plahn, and C.W. Berridge Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin Brain Res. 943 2002 224 236
6. W.E. Flacke, J.W. Flacke, B.C. Bloor, D.F. McIntee, and M. Sagan Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog J. Cardiothorac. Vasc. Anesth. 7 1993 41 49
7. N. Fujiki, Y. Yoshida, B. Ripley, K. Honda, E. Mignot, and S. Nishino Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 h and in response to food deprivation Neuroreport 12 2001 993 997
8. J.M. Gillard, A.N. Nicholson, P.A. Pascoe, Neurotransmitter systems, in: M.H. Kryger, T. Roth, W.C. Dement (Eds.), Principles and Practice of Sleep Medicine, Philadelphia, W.B. Saunders Co., pp. 338-354.
9. A. Gobert, J.M. Rivet, V. Audinot, A. Newman-Tancredi, L. Cistarelli, and M.J. Millan Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release Neuroscience 84 1998 413 429
10. J.J. Hagan, R.A. Leslie, S. Patel, M.L. Evans, T.A. Wattam, S. Holmes, C.D. Benham, S.G. Taylor, C. Routledge, P. Hemmati, R.P. Munton, T.E. Ashmeade, A.S. Shah, J.P. Hatcher, P.D. Hatcher, D.N. Jones, M.I. Smith, D.C. Piper, A.J. Hunter, R.A. Porter, and N. Upton Orexin A activates locus coeruleus cell firing and increases arousal in the rat Proc. Natl. Acad. Sci. U.S.A. 96 1999 10911 10916
11. J.T. Heaton, and S.E. Brauth Effects of yohimbine as a reversing agent for ketamine-xylazine anesthesia in budgerigars Lab. Anim. Sci. 42 1992 54 56
12. K. Hirota, T. Kushikata, M. Kudo, T. Kudo, D.G. Lambert, and A. Matsuki Orexin A and B evoke noradrenaline release from rat cerebrocortical slices Br. J. Pharmacol. 134 2001 1461 1466
13. C.W. Hogue Jr., P. Talke, P.K. Stein, C. Richardson, P.P. Domitrovich, and D.I. Sessler Autonomic nervous system responses during sedative infusions of dexmedetomidine Anesthesiology 97 2002 592 598
14. C.M. Jorm, and J.A. Stamford Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices Br. J. Anaesth. 71 1993 447 449
15. O. Kanno, and P. Clarenbach Effect of clonidine and yohimbine on sleep in man: polygraphic study and EEG analysis by normalized slope descriptors Electroencephalogr. Clin. Neurophysiol. 60 1985 478 484
16. T.S. Kilduff, and C. Peyron The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders Trends Neurosci. 23 2000 359 365
17. L.I. Kiyashchenko, B.Y. Mileykovskiy, N. Maidment, H.A. Lam, M.F. Wu, J. John, J. Peever, and J.M. Siegel Release of hypocretin (orexin) during waking and sleep states J. Neurosci. 22 2002 5282 5286
18. T. Kushikata, K. Hirota, H. Yoshida, T. Kubota, H. Ishihara, and A. Matsuki Alpha-2 adrenoceptor activity affects propofol-induced sleep time Anesth. Analg. 94 2002 1201 1206
19. T. Kushikata, K. Hirota, H. Yoshida, M. Kudo, D.G. Lambert, D. Smart, J.C. Jerman, A. Matsuki, Orexinergic neuron and barbiturate anesthesia, Neuroscience, in press.
20. J.P. Makela, and I.T. Hilakivi Effect of α-adrenoceptor blockade on sleep and wakefulness in the rat Pharmacol. Biochem. Behav. 24 1986 613 616
21. E. Mignot, S. Taheri, and S. Nishino Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders Nat. Neurosci. 5 2002 1071 1075
22. 2-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine J. Pharmacol. Exp. Ther. 295 2000 1206 1222
23. 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat Anesthesiology 81 1990 1527 1534
24. 2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects Anesthesiology 98 2003 428 436
25. T. Pellejero, J.M. Monti, J. Baglietto, H. Jantos, S. Pazos, V. Cichevski, and M. Hawkins Effects of methoxamine and α-adrenoceptor antagonists, prazosin and yohimbine, on the sleep-wake cycle of the rat Sleep 7 1984 365 372
26. R.C. Prielipp, M.H. Wall, J.R. Tobin, L. Groban, M.A. Cannon, F.H. Fahey, H.D. Gage, D.A. Stump, R.L. James, J. Bennett, and J. Butterworth Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow Anesth. Analg. 95 2002 1052 1059
27. I. Sato-Suzuki, I. Kita, Y. Seki, M. Oguri, and H. Arita Cortical arousal induced by microinjection of orexins into the paraventricular nucleus of the rat Behav. Brain Res. 128 2002 169 177
28. J.G. Sutcliffe, and L. de Lecea The hypocretins: setting the arousal threshold Nat. Rev. Neurosci. 3 2002 339 349
29. Y. Yoshida, N. Fujiki, T. Nakajima, B. Ripley, H. Matsumura, H. Yoneda, E. Mignot, and S. Nishino Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities Eur. J. Neurosci. 14 2001 1075 1081